Clinical Trial Update: Assess the Safety and Efficacy of CsA Ophthalmic Gel in Subjects With Dry Eye [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating the safety and efficacy of CsA ophthalmic gel for dry eye has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dry Eye

Drugs mentioned

• CsA ophthalmic gel (cyclosporine ophthalmic gel)

Snippet

Sponsor: Zhaoke (Guangzhou) Ophthalmology Pharmaceutical Ltd. | Conditions: Dry Eye | Phase 2 | Status: COMPLETED